Chronic idiopathic myelofibrosis terminating in extramedullary anaplastic plasmacytoma

References

• Thiele J, Pierre R, Imbert M, Vardiman J W, Brunning R D, Flandrin G. Chronic idiopathic myelofibrosis. WHO Classification of Tumors, Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues, E S Jaffe, N L Harris, H Stein, J W Vardiman. IARC Press, LyonFrance 2001; 35–38
   Google Scholar
• Tefferi A. Myelofibrosis with myeloid metaplasia. N Engl J Med 2000; 342: 1255–1265
   PubMed Web of Science ®Google Scholar
• Thiele J, Kvasnicka H M, Werden C, Zankovich R, Diehl V, Fischer R. Idiopathic primary osteo-myelofibrosis: a clinico-pathological study on 208 patients with special emphasis on evolution of disease features, differentiation from essential thrombocythemia and variables of prognostic impact. Leuk Lymphoma 1996; 22: 303–317
   PubMed Web of Science ®Google Scholar
• Cervantes F, Barosi G, Demory J L, Reilly J, Guarnone R, Dupriez B, et al. Myelofibrosis with myeloid metaplasia in young individuals: disease characteristics, prognostic factors and identification of risk groups. Br J Haematol 1998; 102: 684–690
   PubMed Web of Science ®Google Scholar
• Mesa R A, Li C Y, Ketterling R P, Schroeder G S, Knudson R A, Tefferi A. Leukemic transformation in myelofibrosis with myeloid metaplasia: a single-institution experience with 91 cases. Blood 2005; 105: 973–877
   PubMed Web of Science ®Google Scholar
• Cervantes F, Tassies D, Salgado C, Rovira M, Pereira A, Rozman C. Acute transformation in nonleukemic chronic myeloproliferative disorders: actuarial probability and main characteristics in a series of 218 patients. Acta Haematol 1991; 85: 124–127
   PubMed Web of Science ®Google Scholar
• Chan A C, Kwong Y L, Lam C C. Granulocytic sarcoma of megakaryoblastic differentiation complicating chronic idiopathic myelofibrosis. Hum Pathol 1996; 27: 417–420
   PubMed Web of Science ®Google Scholar
• Garcia S, Miguel A, Linares M, Navarro M, Colomina P. Idiopathic myelofibrosis terminating in erythroleukemia. Am J Hematol 1989; 32: 70–71
   PubMed Web of Science ®Google Scholar
• Hernandez J M, San Miguel J F, Gonzalez M, Orfao A, Canizo M C, Bascones C, et al. Development of acute leukaemia after idiopathic myelofibrosis. J Clin Pathol 1992; 45: 427–430
   PubMed Web of Science ®Google Scholar
• Kimura A, Kawaishi K, Nakata Y, Hyodo H, Kuramoto A, Satow Y. Leukemic transformation of primary myelofibrosis: immunophenotype, genotype and growth characteristics of blast cells. Leuk Lymphoma 1995; 19: 493–498
   PubMed Web of Science ®Google Scholar
• Silverstein M N, Brown A L, Jr, Linman J W. Idiopathic myeloid metaplasia. Its evolution into acute leukemia. Arch Intern Med 1973; 132: 709–712
   PubMed Web of Science ®Google Scholar
• Albo C, Solominos de Marcos N, Dios A, Poderos C, Carrero J. Development of non-Hodgkin's lymphoma in the course of idiopathic myelofibrosis. Sangre (Barc) 1994; 39: 127–128
   PubMedGoogle Scholar
• Epstein R J, Joshua D E, Kronenberg H. Idiopathic myelofibrosis complicated by lymphoma. Report of two cases. Acta Haematol 1985; 73: 40–44
   PubMed Web of Science ®Google Scholar
• Polliack A, Prokocimer M, Matzner Y. Lymphoblastic leukemic transformation (lymphoblastic crisis) in myelofibrosis and myeloid metaplasia. Am J Hematol 1980; 9: 211–220
   PubMed Web of Science ®Google Scholar
• Borowitz M, Bach B A, Bauer K D, Duque R E, Horton A F, Johnson R L, et al. Clinical applications of flow cytometry: Immunophenotyping of leukemic cells; Proposed guideline of National Committee for Clinical Laboratory Standards. NCCLS Document H43-P 1993; 13: 1–105
   Google Scholar
• Wan J H, Trainor K J, Brisco M J, Morley A A. Monoclonality in B cell lymphoma detected in paraffin wax embedded sections using the polymerase chain reaction. J Clin Pathol 1990; 43: 888–890
   PubMed Web of Science ®Google Scholar
• Fodinger M, Winkler K, Mannhalter C, Chott A. Combined polymerase chain reaction approach for clonality detection in lymphoid neoplasms. Diagn Mol Pathol 1999; 8: 80–91
   PubMed Web of Science ®Google Scholar
• McGuire T, Greally J, Leon J, Luka J. Epstein-Barr virus (herpesvirus 4) types A, B and herpesvirus-6 variants A and B in patients presenting with recurrent upper respiratory inflammation, persistent paravertebral thoraco-lumbar muscle spasm and fatigue by polymerase chain reaction (PCR). In Vivo 1997; 11: 23–28
   PubMed Web of Science ®Google Scholar
• Brunning R D, Matutes E, Flandrin G, Vardiman J W, Bennett J, Head D, . Acute myeloid leukemia not otherwise categorised. WHO Classification of Tumors, Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues, E S Jaffe, N L Harris, H Stein, J W Vardiman, et al. IARC Press, LyonFrance 2001; 104–105
   Google Scholar
• Duhrsen U, Uppenkamp M, Meusers P, Konig E, Brittinger G. Frequent association of idiopathic myelofibrosis with plasma cell dyscrasias. Blut 1988; 56: 97–102
   PubMedGoogle Scholar
• Schmidt U, Ruwe M, Leder L D. Multiple myeloma with bone marrow biopsy features simulating concomitant chronic idiopathic myelofibrosis. Nouv Rev Fr Hematol 1995; 37: 159–163
   PubMedGoogle Scholar
• Meerkin D, Ashkenazi Y, Gottschalk-Sabag S, Hershko C. Plasma cell dyscrasia with marrow fibrosis. A reversible syndrome mimicking agnogenic myeloid metaplasia. Cancer 1994; 73: 625–628
   PubMed Web of Science ®Google Scholar
• Allen S L, Coleman M. Aggressive phase multiple myeloma: a terminal anaplastic transformation resembling high-grade lymphoma. Cancer Invest 1990; 8: 417–424
   PubMed Web of Science ®Google Scholar
• Lee S L. Anaplastic transformation of multiple myeloma. Cancer Invest 1990; 8: 569
   PubMed Web of Science ®Google Scholar
• Strand W R, Banks P M, Kyle R A. Anaplastic plasma cell myeloma and immunoblastic lymphoma. Clinical, pathologic, and immunologic comparison. Am J Med 1984; 76: 861–867
   PubMed Web of Science ®Google Scholar
• Papadaki H A, Stefanaki K, Kanavaros P, Katonis P, Papastathi H, Valatas W, et al. Epstein-Barr virus-associated high-grade anaplastic plasmacytoma in a renal transplant patient. Leuk Lymphoma 2000; 36: 411–415
   PubMed Web of Science ®Google Scholar
• Ruiz-Arguelles G J, San Miguel J F. Cell surface markers in multiple myeloma. Mayo Clin Proc 1994; 69: 684–690
   PubMed Web of Science ®Google Scholar
• Spier C M, Grogan T M, Durie B G, Richter L C, Vela E, Frutiger Y, et al. T-cell antigen-positive multiple myeloma. Mod Pathol 1990; 3: 302–307
   PubMed Web of Science ®Google Scholar
• Wotherspoon A C, Norton A J, Isaacson P G. Immunoreactive cytokeratins in plasmacytomas. Histopathology 1989; 14: 141–150
   PubMed Web of Science ®Google Scholar
• Carbone A, Gaidano G, Gloghini A, Ferlito A, Rinaldo A, Stein H. AIDS-related plasmablastic lymphomas of the oral cavity and jaws: a diagnostic dilemma. Ann Otol Rhinol Laryngol 1999; 108: 95–99
   PubMed Web of Science ®Google Scholar
• Delecluse H J, Anagnostopoulos I, Dallenbach F, et al. Plasmablastic lymphomas of the oral cavity: a new entity associated with the human immunodeficiency virus infection. Blood 1997; 89: 1413–1420
   PubMed Web of Science ®Google Scholar
• Lin Y, Rodrigues G D, Turner J F, Vasef M A. Plasmablastic lymphoma of the lung: report of a unique case and review of the literature. Arch Pathol Lab Med 2001; 125: 282–285
   PubMed Web of Science ®Google Scholar
• Colomo L, Loong F, Rives S, Pittaluga S, Martinez A, Lopez Guillermo A, et al. Diffuse large B-cell lymphomas with plasmablastic differentiation represent a heterogeneous group of disease entities. Am J Surg Pathol 2004; 28: 736–747
   PubMed Web of Science ®Google Scholar
• Pruneri G, Graziadei G, Ermellino L, Baldini L, Neri A, Buffa R. Plasmablastic lymphoma of the stomach. A case report. Haematologica 1998; 83: 87–89
   PubMed Web of Science ®Google Scholar
• Dupin N, Diss T L, Kellam P, Tulliez M, Du M Q, Sicard D, et al. HHV-8 is associated with a plasmablastic variant of Castleman disease that is linked to HHV-8-positive plasmablastic lymphoma. Blood 2000; 9: 1406–1412
   Google Scholar
• Vega F, Chang C C, Medeiros L J, Udden M M, Cho-Vega J H, Lau C C, et al. Plasmablastic lymphomas and plasmablastic plasma cell myelomas have nearly identical immunophenotypic profiles. Mod Pathol 2005; 18: 806–815
   PubMed Web of Science ®Google Scholar